E4/DRSP FDA Approval Status
Last updated by Judith Stewart, BPharm on June 25, 2020.
E4/DRSP (estetrol and drospirenone) is a novel combined hormonal oral contraceptive pill in development for the prevention of pregnancy.
Development Timeline for E4/DRSP
|Jun 24, 2020||Mayne Pharma Announces FDA Filing Acceptance of New Drug Application for E4/DRSP in the US|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.